Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
0%
OVERLAP
BY WEIGHT
0
# OF OVERLAPPING
HOLDINGS
HRTS
42
HOLDINGS
0%
ALSO IN
HOLDINGS
nan%
ALSO IN HRTS
SECTOR DRIFT (HRTS minus )
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in HRTS |
Weight in |
Overlap | |
|---|---|---|---|---|
HRTS Overweight Relative to
 |
ELI LILLY & CO | 10.0% |
|
ABBOTT LABORATORIES | 4.4% |
 |
NOVO NORDISK A/S-B | 4.3% |
 |
ROCHE HOLDINGS LTD-SPONS ADR | 4.1% |
|
UNITEDHEALTH GROUP INC | 4.0% |
 |
ASTRAZENECA PLC | 4.0% |
|
BOSTON SCIENTIFIC CORP | 3.4% |
|
GILEAD SCIENCES INC | 3.3% |
|
BRIDGEBIO PHARMA, INC. | 3.3% |
|
NOVARTIS AG | 3.2% |
HRTS Underweight Relative to
|
ROCKET PHARMACEUTICALS, INC. | 0.2% |
|
INTELLIA THERAPEUTICS, INC. | 0.4% |
|
WEST PHARMACEUTICAL SERVICES | 0.5% |
|
SCHOLAR ROCK HOLDING CORP. | 0.7% |
|
INSMED INC | 0.9% |
|
MIRUM PHARMACEUTICALS, INC. | 1.0% |
|
AKERO THERAPEUTICS, INC. | 1.0% |
|
NEUROCRINE BIOSCIENCES INC | 1.0% |
|
MADRIGAL PHARMACEUTICALS, INC. | 1.1% |
|
VIKING THERAPEUTICS, INC. | 1.2% |